Disclosed in the present invention is a compound of Formula (I), a geometric or optical isomer, a pharmaceutically acceptable salt, a solvate or a polymorph thereof. Also disclosed in the present invention is a composition comprising the compound of Formula (I), the geometric or optical isomer, the pharmaceutically acceptable salt, the solvate or the polymorph thereof. Also disclosed in the present invention is a use of the compound of Formula (I), the geometric or optical isomer, the pharmaceutically acceptable salt, the solvate or the polymorph thereof in the treatment of a disease or disorder such as a hypoglutamatergic condition, a neurodegenerative disease or respiratory depression, particularly in the treatment of a disease or disorder associated with AMPA receptor.
本发明公开了式(I)化合物、几何或光学异构体、药学上可接受的盐、其溶解物或多晶型物。本发明还公开了一种包含式(I)化合物、几何或光学异构体、药学上可接受的盐、其溶液或其多晶型的组合物。本发明还公开了式(I)化合物、几何异构体或光学异构体、药学上可接受的盐、其溶解物或其多晶型在治疗疾病或紊乱中的用途,例如低谷
氨酸症、神经退行性疾病或呼吸抑制,特别是在治疗与
AMPA受体相关的疾病或紊乱中的用途。